Latest Sobi News & Updates
See the latest news and media coverage for Sobi. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biopharmaceutical company focused on rare diseases
sobi.com- Headquarters
- Stockholm, Sweden
- Company type
- Public company
- Number of employees
- 2,200–5,000
Latest news about Sobi
Company announcements
-
Sobi maintains No. 2 position in patient engagement
This marks the second consecutive year in PatientView's Global Corporate Reputation report. Sobi excels in patient centricity, safety, and integrity. Previously ranked No. 1 in Rare Disease Edition.
-
Sobi shares strong Q1 performance
Driven by successful launches, pipeline progress, and regulatory submissions in Europe. CEO highlights commitment to rare disease treatments.
-
Sobi announces Q1 2026 financial results
Total revenue increased 24% at CER to SEK 7,184M. Strong growth in haematology and immunology. Arthrosi Therapeutics acquisition completed. Outlook unchanged.
-
Sobi reaches 1 billion units milestone with WFH
Sobi and Sanofi delivered 1 billion units of factor therapies via the WFH Humanitarian Aid Program, expanding access in underserved areas.
Media coverage
-
UK nod for Sobi’s Aspaveli for C3G and primary IC-MPGN
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Aspaveli (pegcetacoplan) to treat patients aged 12 to 17 years with C3 glomerulopathy (C3G...
-
Swedish Orphan Biovitrum Receives Health Canada Approval for EMPAVELI (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN
EMPAVELI (pegcetacoplan) is the first approved treatment for C3G or primary IC-MPGN for patients 12 years and older in Canada Approval supported by Phase 3...
-
Narrow-Moat Sobi's Strategic Portfolio Drives Strong Growth as Pipeline Advances
Since then, the successful launches of hemophilia drugs Elocta and Alprolix in Europe and other international markets, and several acquisitions and collaborations have expanded Sobi's...
-
Invitation: Sobi's Q1 2026 report
Investors, analysts, and the media are invited to a conference call on the same day at 12:30 CEST, 11:30 BST, and 06:30 EDT. The call...
Track Sobi and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Sobi competitors & trending companies
Browse news for competitors to Sobi and other trending companies.
Ipsen
Biogen
Advanz Pharma
Disc Medicine
Precigen
Hansa Biopharma
Kyowa Kirin
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore
BlueConic
Amperity
Wero
BLIK
EPI
Swish
Affirm
Brite Payments
TCS
Overview Energy
Adfin
Ineffable Intelligence
Mechanize
Hexatronic
Alimak Group
Lindab Group